Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.63 |
| ▸ | OPRD1 | P41143 | 10/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.60 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.60 |
| ▸ | YARS1 | P54577 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4018497 | 1.00 | SLC7A5 (0.63) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL4018493 | 1.00 | SLC7A5 (0.63) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL238988 | 1.00 | SLC7A5 (0.63) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL10716722 | 0.97 | OPRD1 (0.61) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL10716732 | 0.97 | OPRD1 (0.61) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL10621141 | 0.97 | OPRD1 (0.61) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL29822851 | 0.93 | OPRD1 (0.64) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL22644029 | 0.92 | OPRD1 (0.55) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL30792491 | 0.91 | OPRD1 (0.53) | SLC7A5OPRD1OPRM1OPRK1YARS1 | |
| SCHEMBL29431826 | 0.91 | OPRD1 (0.55) | SLC7A5OPRD1OPRM1OPRK1YARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0412061-B1 | 2-(N-acyl)amino-6,7-dimethoxy tetralines, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same | SIGMA TAU IND FARMACEUTI (IT) | 1994-10-05 | — | — | EP | claimed |
| EP-0457314-A1 | Nutrient compositions containing peptides | CLINTEC NUTRITION COMPANY (US) | 1991-11-21 | — | — | EP | claimed |
| EP-0412061-A2 | 2-(N-acyl)amino-6,7-dimethoxy tetralines, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1991-02-06 | — | — | EP | claimed |
| JP-62033180-A | — | — | None | — | — | JP | disclosed |
| CN-116836220-A | Active peptide containing tryptophan and cysteine and application thereof | 中山大学 | 2023-10-03 | — | — | CN | disclosed |
| EP-3512486-B1 | BLUE POWDER AND USE THEREOF IN COSMETICS | OREAL (FR) | 2020-10-21 | — | — | EP | disclosed |
| EP-3512486-A1 | BLUE POWDER AND USE THEREOF IN COSMETICS | L'Oreal (FR) | 2019-07-24 | — | — | EP | disclosed |
| CN-109689010-A | Blue powder and its purposes in cosmetics | 莱雅公司 | 2019-04-26 | — | — | CN | disclosed |
| EP-2765190-B1 | MUTANT Y-GLUTAMYLTRANSFERASE, AND METHOD FOR PRODUCING Y-GLUTAMYLVALYLGLYCINE OR SALT THEREOF | AJINOMOTO KK (JP) | 2018-05-23 | — | — | EP | disclosed |
| WO-2018050504-A1 | BLUE POWDER AND USE THEREOF IN COSMETICS | L'OREAL (FR) | 2018-03-22 | — | — | WO | disclosed |
| US-9677106-B2 | Method for producing gamma-glutamylvalylglycine or a salt thereof | AJINOMOTO CO., INC. (JP) | 2017-06-13 | — | — | US | disclosed |
| EP-0212550-A2 | Substituted dipeptide amides | G.D. Searle & Co. (US) | 1987-03-04 | — | — | EP | disclosed |
| JP-S6233180-A | NOVEL PORPHYRINE COMPOUND | ASAHI CHEM IND CO LTD | 1987-02-13 | — | — | JP | disclosed |
| US-4599325-A | ANALGESIC, HYPOTENSIVE | G. D. SEARLE & CO. (US) | 1986-07-08 | — | — | US | disclosed |
| US-4599325-A | ANALGESIC, HYPOTENSIVE | G. D. SEARLE & CO. (US) | 1986-07-08 | — | — | US | disclosed |
| US-4599325-A | ANALGESIC, HYPOTENSIVE | G. D. SEARLE & CO. (US) | 1986-07-08 | — | — | US | disclosed |
| EP-0154234-A2 | Substituted tyrosil alanine dipeptide amides | G.D. Searle & Co. (US) | 1985-09-11 | — | — | EP | disclosed |
| EP-0154234-A2 | Substituted tyrosil alanine dipeptide amides | G.D. Searle & Co. (US) | 1985-09-11 | — | — | EP | disclosed |
| EP-0154234-A2 | Substituted tyrosil alanine dipeptide amides | G.D. Searle & Co. (US) | 1985-09-11 | — | — | EP | disclosed |
| US-4242256-A | Synthesis of peptide analogues | SHARPE ROBERT (GB) | 1980-12-30 | — | — | US | disclosed |